Developer docs
API playgroundTry for free, no card

Search company profiles

Fermentalg

Full company profile

uuid0004qp2

Namestring
Fermentalg
Legal namestring
Fermentalg
Websiteurl
fermentalg.com
Company typeenum
Public
Founded yearint
2009
Descriptiontext

Fermentalg is a French publicly traded biotech (Euronext Growth Paris, ticker ALXP, ~70 employees, headquartered in Libourne) that produces sustainable BioSolutions from aquatic micro-organisms — primarily microalgae — using proprietary precision fermentation and precision photosynthesis platforms. The company operates across a vertically integrated value chain spanning microbiology (a 2,500+ cryopreserved strain library), precision fermentation, industrial scale-up, and applications/formulation, with 229 patents protecting strain development, fermentation processes and extraction technologies.

Its commercial portfolio centers on three families. (1) Functional lipids under the OMEGA ΩRIGINS™ brand, including the DHA ORIGINS® sub-range, derived from a proprietary Schizochytrium sp. FCC-3204 strain via patented precision fermentation — the flagship 400/200 ratio delivers 40% EPA + 20% DHA and up to 60% total omega-3 content without any concentration step. (2) Galdieria Blue™, a naturally derived acid-stable blue colorant produced from Galdieria sulphuraria via precision fermentation, stable down to pH 3 and heat resistant, commercialized worldwide by Givaudan under the Everzure™ brand. (3) Kalveā® algal proteins and peptides for pet nutrition. Industrial production is performed at HuvePharma's European facilities (Europe's largest fermentation capacity at ~10,000 m³) under an OEM partnership, with a 100 tons/year Everzure target by 2026.

Fermentalg sells ingredients B2B to nutritional, dietary supplement, food & beverage, and pet nutrition manufacturers, with no public pricing disclosed. Givaudan handles global formulation and commercialization of the blue colorant, while a direct field-sales team ([email protected]) handles other ingredient inquiries. The company has secured FDA approval for Galdieria Blue (May 2025) and an EFSA positive opinion (March 2026), along with FSSC 22000, ISO 22000, ISO 14001, EcoVadis Gold and EthiFinance Platinum ESG ratings. A non-core joint venture, CarbonWorks (with SUEZ and financial investors BNP Paribas, Bpifrance, Demeter and Naco), extends the platform into precision photosynthesis for carbon capture and bio-based molecule production.

Short descriptiontext

French public biotech producing sustainable microalgae-derived BioSolutions — omega-3 EPA/DHA oils, acid-stable natural blue colorant, and algal proteins — via precision fermentation and photosynthesis platforms, supplying nutritional, food & beverage, and pet nutrition manufacturers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLibourne, France
HQ citystring
Libourne
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microalgae biotechnology, algal omega-3 oils, natural blue pigments, algal protein ingredients, precision fermentation
Industry4 codes
1Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids)
CodeAFAJAKACPrimaryYes
2Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
CodeAFAJAHAFPrimaryNo
3Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates)
CodeAFAJALAKPrimaryNo
4Alternative Protein & Sustainable Pet Food (insect/plant/cell-based)
CodeCRADAFAIPrimaryNo
NAICS code1 code
  • Fats and Oils Refining and Blending311225
SIC code1 code
  • Fats & Oils2070
Product category
Microalgae-derived Bioingredients
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1BioSolutions Ingredients Sales
TypeOne Time License
Description

Sale of microalgae-derived ingredients including Omega-3 oils (OMEGA ΩRIGINS, DHA ORIGINS), natural blue colorants (Galdieria Blue/Everzure), and algal proteins (Kalvea) to nutritional, food, beverage, supplement, and pet nutrition manufacturers.

fermentalg.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1ΩRIGINS™
Description

Functional lipids - the purest source of Omega-3s naturally concentrated from microalgae for health at every stage of life.

fermentalg.com
+2 more records
Core offering1 text field

Fermentalg develops and industrializes sustainable BioSolutions derived from aquatic microalgae using proprietary precision fermentation and precision photosynthesis platforms. Its product portfolio centers on three families: functional lipids (Omega-3 EPA/DHA oils under the ΩRIGINS™ and DHA ORIGINS® brands), natural colorants (acid-stable blue pigment Galdieria Blue™ / Everzure™), and functional proteins (Kalveā® algal proteins for pet nutrition), designed in France and produced in Europe for nutritional, food & beverage, and pet health manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 40% EPA + 20% DHA concentration achieved naturally without concentration steps
+6 more records
Product overview1 text field

Fermentalg is a biotech company developing and producing sustainable BioSolutions derived from aquatic microalgae and other microorganisms. Its product portfolio centers on three core BioSolution families: (1) functional lipids — primarily omega-3 EPA/DHA oils under the ΩRIGINS™ brand (including DHA ORIGINS® sub-brand), produced via precision fermentation from proprietary Schizochytrium sp. strains; (2) natural colorants — the acid-stable natural blue pigment Galdieria Blue™, commercialized by Givaudan under the Everzure™ brand; and (3) functional proteins — Kalveā® algal proteins for pet nutrition. Products are designed in France and produced in Europe, targeting infant nutrition, dietary supplements, food & beverages, and pet health markets. The company also operates a joint venture (CarbonWorks) focused on precision photosynthesis technology for carbon capture and bio-based molecule production.

Product and service5 records
1OMEGA ΩRIGINS™ EPA/DHA
CategoryFunctional lipids — Omega-3 EPA/DHA oils
Description

A range of omega-3-rich algal oils derived from proprietary Schizochytrium sp. FCC-3204 strain via patented precision fermentation. Flagship ratio 400/200 delivers 40% EPA and 20% DHA — the highest naturally concentrated EPA/DHA from microalgae without any concentration step. Total omega-3 content reaches up to 60%. Available in multiple ratios (400/200, 300/200, 150/300, 100/500), formats (oil, powder) and colors (yellow, orange). Targeted at dietary supplement, functional food & beverage and pet nutrition manufacturers.

2DHA ORIGINS®
CategoryFunctional lipids — DHA oils
Description

Premium plant-based DHA oils from Schizochytrium sp. microalgae offering multiple DHA concentrations (170, 400, 510, 550 mg/g) in triglyceride form, with a minimum guaranteed 550 mg/g DHA content. EFSA authorized at 1g DHA/day, GMO-free, solvent-free extraction, free from heavy metals and contaminants. GOED member quality standards. Provides four times more DHA than currently authorized dose for similar oils (1g DHA/day authorized vs typical 250mg).

3Galdieria Blue™
CategoryNatural colorants — natural blue pigment
Description

Next-generation antioxidant and vibrant natural blue pigment derived from the extremophile microalgae Galdieria sulphuraria via precision fermentation. The first naturally derived blue colorant combining high stability with acid resistance (stable down to pH 3 and heat resistant), enabling performance in acidic beverages, confectionery, fruit preparations, bakery and dairy — applications historically dominated by synthetic dyes. FDA-approved (May 2025); EFSA positive opinion (March 2026) pending EU authorization. Commercialized globally via Givaudan under the Everzure™ brand.

4Everzure™ Galdieria
CategoryNatural colorants — co-branded natural blue ingredient
Description

Co-branded commercial offering of Fermentalg's Galdieria Blue natural blue colorant marketed by Givaudan (the world's largest flavor and fragrance company) under the Everzure brand. Produced through precision fermentation by HuvePharma, positioned as a bio-based, petroleum-free alternative to synthetic Brilliant Blue FCF (E133) for global food and beverage manufacturers seeking clean-label natural color solutions.

5Kalveā®
CategoryFunctional proteins — algal proteins for pet nutrition
Description

A new generation of natural, non-animal proteins and peptides sourced from microalgae, designed specifically for optimal pet nutrition. Provides a sustainable, algae-derived protein ingredient for pet health and nutrition applications, addressing demand for natural, sustainable and traceable pet food ingredients.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Strategic alliance for industrial-scale Omega-3 production with HuvePharma, a European leader in precision fermentation with access to Europe's largest fermentation capacity (~10,000 m³). Fermentalg provides strain innovation, process design, and upstream/downstream optimization. HuvePharma handles large-scale industrial manufacturing of ΩRIGINS Omega-3 and Everzure Galdieria. Key achievements include full transfer of Omega-3 production in 2024 (+40% productivity), refining unit opening in 2025, and industrial transfer of Everzure targeting 100 tons/year by 2026. HuvePharma is also a strategic shareholder and board member.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Partnership for co-development and commercialization of Everzure Galdieria natural blue colorant for food and beverages. Fermentalg provides strain development (Galdieria sulphuraria), fermentation expertise, and process industrialization. Givaudan handles formulation, pre-marketing tests with global food groups, and worldwide commercialization under the Everzure brand. Industrial production started in 2024. Breakthrough stability down to pH 3 and heat resistance make Everzure ideal for beverages, confectionery, bakery, and dairy. Givaudan is the world's largest flavor and fragrance company.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Long-standing partnership dating back to 2015 for microalgae and photosynthesis applications. Led to the establishment of CarbonWorks joint venture for carbon capture and utilization. Fermentalg contributes microalgae expertise, strain selection, and biotechnology development. SUEZ provides environmental engineering, infrastructure, and industrial deployment. Key achievements include development of patented photobioreactor technology (11 patent families) with unique surface efficiency and scalable potential. Applications include functional lipids, pigments, biocontrol, and biostimulants.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Joint venture between Fermentalg and SUEZ established to pioneer Precision Photosynthesis technology. Addresses the critical gap in harnessing photosynthetic capabilities of photosynthetic microorganisms for industrial applications. Focuses on leveraging photosynthetic microorganisms through Precision Photosynthetic IPS for production of high-value molecules including biocidal agents, recombinant proteins, and other active compounds uniquely accessible via photosynthesis. Fermentalg CEO serves as president; operationally managed by Imanol de Cherisey.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The world's largest producer of algae-based DHA/EPA omega-3 oils (Veramaris, life's OMEGA) and a leading nutritional ingredients supplier. Directly comparable to Fermentalg in microalgae-derived functional lipids, B2B ingredient sales to nutrition and F&B customers, and global commercialization of food ingredients.

TypeDirect peer
Description

Spanish microalgae biotechnology company developing microalgae-based solutions for agriculture, food, and aquaculture. Comparable to Fermentalg as a microalgae platform company pursuing industrial-scale applications across multiple end markets using proprietary strains.

TypeDirect peer
Description

Global leader in plant-based ingredients, including pea protein and emerging algae-based protein offerings for food, nutrition, and pet food applications. Comparable to Fermentalg in the alternative protein and fermentation-derived ingredient categories serving F&B and pet nutrition markets.

TypeDirect peer
Description

US-based natural ingredient company specializing in colors (from sources including algae), flavors, and plant extracts for the food and beverage industry. Comparable to Fermentalg as a specialty natural colorant supplier serving clean-label reformulation needs in F&B.

TypeDirect peer
Description

Specialist supplier of natural and synthetic colors, flavors, and fragrances for food, beverage, and personal care applications. Directly comparable to Fermentalg as a B2B natural colorant supplier competing in the same food and beverage formulation market.

TypeBroad incumbent
Description

Formed from the merger of Novozymes and Chr. Hansen, Novonesis is a global leader in microbial solutions, food cultures, enzymes, and natural ingredients. Comparable as a broad-incumbent supplier of fermentation-derived ingredients and natural color solutions to F&B manufacturers, though much larger and more diversified than Fermentalg.

TypeDirect peer
Description

Hawaiian microalgae company producing Spirulina and natural astaxanthin from Haematococcus pluvialis for nutrition, supplements, and food applications. Directly comparable as a vertically integrated microalgae-to-ingredient B2B supplier in the natural ingredients space.

8GNT Group
TypeDirect peer
Description

Specialist in plant- and algae-based natural colorants (EXBERRY brand), with a particular strength in blue and green shades from edible sources. Closest direct competitor to Fermentalg in the acid-stable natural blue colorant category for F&B applications.

TypeBroad incumbent
Description

One of the world's largest food and feed ingredient companies, with a portfolio spanning oils, alternative proteins, and algae-derived omega-3 (via partnerships such as AlgaeOil). Comparable as a broad incumbent in the omega-3 and functional ingredient categories, with significantly greater scale and customer reach.

10ADM
TypeBroad incumbent
Description

Global agribusiness and food/feed ingredient supplier with strong positions in plant-based proteins, natural colors, and nutrition. Comparable as a broad incumbent in alternative proteins, natural colorants, and functional lipids, though much larger and more diversified than Fermentalg.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fermentalg

Microalgae-derived Bioingredientsfermentalg.com

French public biotech producing sustainable microalgae-derived BioSolutions — omega-3 EPA/DHA oils, acid-stable natural blue colorant, and algal proteins — via precision fermentation and photosynthesis platforms, supplying nutritional, food & beverage, and pet nutrition manufacturers worldwide.

What Fermentalg does

Fermentalg is a French publicly traded biotech (Euronext Growth Paris, ticker ALXP, ~70 employees, headquartered in Libourne) that produces sustainable BioSolutions from aquatic micro-organisms — primarily microalgae — using proprietary precision fermentation and precision photosynthesis platforms. The company operates across a vertically integrated value chain spanning microbiology (a 2,500+ cryopreserved strain library), precision fermentation, industrial scale-up, and applications/formulation, with 229 patents protecting strain development, fermentation processes and extraction technologies.

Its commercial portfolio centers on three families. (1) Functional lipids under the OMEGA ΩRIGINS™ brand, including the DHA ORIGINS® sub-range, derived from a proprietary Schizochytrium sp. FCC-3204 strain via patented precision fermentation — the flagship 400/200 ratio delivers 40% EPA + 20% DHA and up to 60% total omega-3 content without any concentration step. (2) Galdieria Blue™, a naturally derived acid-stable blue colorant produced from Galdieria sulphuraria via precision fermentation, stable down to pH 3 and heat resistant, commercialized worldwide by Givaudan under the Everzure™ brand. (3) Kalveā® algal proteins and peptides for pet nutrition. Industrial production is performed at HuvePharma's European facilities (Europe's largest fermentation capacity at ~10,000 m³) under an OEM partnership, with a 100 tons/year Everzure target by 2026.

Fermentalg sells ingredients B2B to nutritional, dietary supplement, food & beverage, and pet nutrition manufacturers, with no public pricing disclosed. Givaudan handles global formulation and commercialization of the blue colorant, while a direct field-sales team ([email protected]) handles other ingredient inquiries. The company has secured FDA approval for Galdieria Blue (May 2025) and an EFSA positive opinion (March 2026), along with FSSC 22000, ISO 22000, ISO 14001, EcoVadis Gold and EthiFinance Platinum ESG ratings. A non-core joint venture, CarbonWorks (with SUEZ and financial investors BNP Paribas, Bpifrance, Demeter and Naco), extends the platform into precision photosynthesis for carbon capture and bio-based molecule production.

Fermentalg firmographics

Firmographics
Name
Fermentalg
Legal name
Fermentalg
Website
https://fermentalg.com
Company type
Public
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
French public biotech producing sustainable microalgae-derived BioSolutions — omega-3 EPA/DHA oils, acid-stable natural blue colorant, and algal proteins — via precision fermentation and photosynthesis platforms, supplying nutritional, food & beverage, and pet nutrition manufacturers worldwide.
Ownership category
akta.pro rank

Fermentalg industry classification

Industry
Product category
Microalgae-derived Bioingredients
NAICS
Fats and Oils Refining and Blending (311225)
SIC
Fats & Oils (2070)
akta.pro primary industry
Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)
akta.pro secondary industries
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates) (AFAJALAK), Alternative Protein & Sustainable Pet Food (insect/plant/cell-based) (CRADAFAI)

Keywords

  • Microalgae biotechnology
  • Algal omega-3 oils
  • Natural blue pigments
  • Algal protein ingredients
  • Precision fermentation

Where Fermentalg is headquartered

Location

Headquarters

HQ city
Libourne
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Fermentalg business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. BioSolutions Ingredients Sales: Sale of microalgae-derived ingredients including Omega-3 oils (OMEGA ΩRIGINS, DHA ORIGINS), natural blue colorants (Galdieria Blue/Everzure), and algal proteins (Kalvea) to nutritional, food, beverage, supplement, and pet nutrition manufacturers.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Fermentalg product offering

Product offering

Core offering

Fermentalg develops and industrializes sustainable BioSolutions derived from aquatic microalgae using proprietary precision fermentation and precision photosynthesis platforms. Its product portfolio centers on three families: functional lipids (Omega-3 EPA/DHA oils under the ΩRIGINS™ and DHA ORIGINS® brands), natural colorants (acid-stable blue pigment Galdieria Blue™ / Everzure™), and functional proteins (Kalveā® algal proteins for pet nutrition), designed in France and produced in Europe for nutritional, food & beverage, and pet health manufacturers.

Product overview

Fermentalg is a biotech company developing and producing sustainable BioSolutions derived from aquatic microalgae and other microorganisms. Its product portfolio centers on three core BioSolution families: (1) functional lipids — primarily omega-3 EPA/DHA oils under the ΩRIGINS™ brand (including DHA ORIGINS® sub-brand), produced via precision fermentation from proprietary Schizochytrium sp. strains; (2) natural colorants — the acid-stable natural blue pigment Galdieria Blue™, commercialized by Givaudan under the Everzure™ brand; and (3) functional proteins — Kalveā® algal proteins for pet nutrition. Products are designed in France and produced in Europe, targeting infant nutrition, dietary supplements, food & beverages, and pet health markets. The company also operates a joint venture (CarbonWorks) focused on precision photosynthesis technology for carbon capture and bio-based molecule production.

Differentiator

Problem solved

Functional benefit

Brands

  • ΩRIGINS™: Functional lipids - the purest source of Omega-3s naturally concentrated from microalgae for health at every stage of life.
  • Galdieria Blue™
  • Kalveā®

Products and services

  • OMEGA ΩRIGINS™ EPA/DHA A range of omega-3-rich algal oils derived from proprietary Schizochytrium sp. FCC-3204 strain via patented precision fermentation. Flagship ratio 400/200 delivers 40% EPA and 20% DHA — the highest naturally concentrated EPA/DHA from microalgae without any concentration step. Total omega-3 content reaches up to 60%. Available in multiple ratios (400/200, 300/200, 150/300, 100/500), formats (oil, powder) and colors (yellow, orange). Targeted at dietary supplement, functional food & beverage and pet nutrition manufacturers.
  • DHA ORIGINS® Premium plant-based DHA oils from Schizochytrium sp. microalgae offering multiple DHA concentrations (170, 400, 510, 550 mg/g) in triglyceride form, with a minimum guaranteed 550 mg/g DHA content. EFSA authorized at 1g DHA/day, GMO-free, solvent-free extraction, free from heavy metals and contaminants. GOED member quality standards. Provides four times more DHA than currently authorized dose for similar oils (1g DHA/day authorized vs typical 250mg).
  • Galdieria Blue™ Next-generation antioxidant and vibrant natural blue pigment derived from the extremophile microalgae Galdieria sulphuraria via precision fermentation. The first naturally derived blue colorant combining high stability with acid resistance (stable down to pH 3 and heat resistant), enabling performance in acidic beverages, confectionery, fruit preparations, bakery and dairy — applications historically dominated by synthetic dyes. FDA-approved (May 2025); EFSA positive opinion (March 2026) pending EU authorization. Commercialized globally via Givaudan under the Everzure™ brand.
  • Everzure™ Galdieria Co-branded commercial offering of Fermentalg's Galdieria Blue natural blue colorant marketed by Givaudan (the world's largest flavor and fragrance company) under the Everzure brand. Produced through precision fermentation by HuvePharma, positioned as a bio-based, petroleum-free alternative to synthetic Brilliant Blue FCF (E133) for global food and beverage manufacturers seeking clean-label natural color solutions.
  • Kalveā® A new generation of natural, non-animal proteins and peptides sourced from microalgae, designed specifically for optimal pet nutrition. Provides a sustainable, algae-derived protein ingredient for pet health and nutrition applications, addressing demand for natural, sustainable and traceable pet food ingredients.

Quantifiable outcome

  • 40% EPA + 20% DHA concentration achieved naturally without concentration steps
  • +6 more outcomes

Companies that use Fermentalg

Customer profile

Segments4 records

Ideal customer profiles4 records

Fermentalg technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Fermentalg partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and strategic.

  • HuvePharmacoreStrategic or Co-development Partner · 1 January 2023Strategic alliance for industrial-scale Omega-3 production with HuvePharma, a European leader in precision fermentation with access to Europe's largest fermentation capacity (~10,000 m³). Fermentalg provides strain innovation, process design, and upstream/downstream optimization. HuvePharma handles large-scale industrial manufacturing of ΩRIGINS Omega-3 and Everzure Galdieria. Key achievements include full transfer of Omega-3 production in 2024 (+40% productivity), refining unit opening in 2025, and industrial transfer of Everzure targeting 100 tons/year by 2026. HuvePharma is also a strategic shareholder and board member.
  • GivaudancoreStrategic or Co-development Partner · 1 January 2020Partnership for co-development and commercialization of Everzure Galdieria natural blue colorant for food and beverages. Fermentalg provides strain development (Galdieria sulphuraria), fermentation expertise, and process industrialization. Givaudan handles formulation, pre-marketing tests with global food groups, and worldwide commercialization under the Everzure brand. Industrial production started in 2024. Breakthrough stability down to pH 3 and heat resistance make Everzure ideal for beverages, confectionery, bakery, and dairy. Givaudan is the world's largest flavor and fragrance company.
  • SUEZstrategicStrategic or Co-development Partner · 1 January 2015Long-standing partnership dating back to 2015 for microalgae and photosynthesis applications. Led to the establishment of CarbonWorks joint venture for carbon capture and utilization. Fermentalg contributes microalgae expertise, strain selection, and biotechnology development. SUEZ provides environmental engineering, infrastructure, and industrial deployment. Key achievements include development of patented photobioreactor technology (11 patent families) with unique surface efficiency and scalable potential. Applications include functional lipids, pigments, biocontrol, and biostimulants.
  • CarbonWorksstrategicStrategic or Co-development PartnerJoint venture between Fermentalg and SUEZ established to pioneer Precision Photosynthesis technology. Addresses the critical gap in harnessing photosynthetic capabilities of photosynthetic microorganisms for industrial applications. Focuses on leveraging photosynthetic microorganisms through Precision Photosynthetic IPS for production of high-value molecules including biocidal agents, recombinant proteins, and other active compounds uniquely accessible via photosynthesis. Fermentalg CEO serves as president; operationally managed by Imanol de Cherisey.

Scale indicators15 records

Recent moves8 records

Expansion highlights5 records

Fermentalg competitors and assessment

Company assessment

Direct peers

  • dsm-firmenich: The world's largest producer of algae-based DHA/EPA omega-3 oils (Veramaris, life's OMEGA) and a leading nutritional ingredients supplier. Directly comparable to Fermentalg in microalgae-derived functional lipids, B2B ingredient sales to nutrition and F&B customers, and global commercialization of food ingredients.
  • AlgaEnergy: Spanish microalgae biotechnology company developing microalgae-based solutions for agriculture, food, and aquaculture. Comparable to Fermentalg as a microalgae platform company pursuing industrial-scale applications across multiple end markets using proprietary strains.
  • Roquette: Global leader in plant-based ingredients, including pea protein and emerging algae-based protein offerings for food, nutrition, and pet food applications. Comparable to Fermentalg in the alternative protein and fermentation-derived ingredient categories serving F&B and pet nutrition markets.
  • Kalsec: US-based natural ingredient company specializing in colors (from sources including algae), flavors, and plant extracts for the food and beverage industry. Comparable to Fermentalg as a specialty natural colorant supplier serving clean-label reformulation needs in F&B.
  • Sensient Technologies: Specialist supplier of natural and synthetic colors, flavors, and fragrances for food, beverage, and personal care applications. Directly comparable to Fermentalg as a B2B natural colorant supplier competing in the same food and beverage formulation market.
  • Cyanotech: Hawaiian microalgae company producing Spirulina and natural astaxanthin from Haematococcus pluvialis for nutrition, supplements, and food applications. Directly comparable as a vertically integrated microalgae-to-ingredient B2B supplier in the natural ingredients space.
  • GNT Group: Specialist in plant- and algae-based natural colorants (EXBERRY brand), with a particular strength in blue and green shades from edible sources. Closest direct competitor to Fermentalg in the acid-stable natural blue colorant category for F&B applications.

Broad incumbents

  • Novonesis: Formed from the merger of Novozymes and Chr. Hansen, Novonesis is a global leader in microbial solutions, food cultures, enzymes, and natural ingredients. Comparable as a broad-incumbent supplier of fermentation-derived ingredients and natural color solutions to F&B manufacturers, though much larger and more diversified than Fermentalg.
  • Cargill: One of the world's largest food and feed ingredient companies, with a portfolio spanning oils, alternative proteins, and algae-derived omega-3 (via partnerships such as AlgaeOil). Comparable as a broad incumbent in the omega-3 and functional ingredient categories, with significantly greater scale and customer reach.
  • ADM: Global agribusiness and food/feed ingredient supplier with strong positions in plant-based proteins, natural colors, and nutrition. Comparable as a broad incumbent in alternative proteins, natural colorants, and functional lipids, though much larger and more diversified than Fermentalg.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Fermentalg social profiles

Digital presence

Fermentalg compliance and trust

Trust signal

Compliance7 records

Fermentalg financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fermentalg leadership team

Management profile

Number of profiles

Profiles13 records

Fermentalg subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Fermentalg funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fermentalg M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fermentalg

What does Fermentalg do?

Fermentalg develops and industrializes sustainable BioSolutions derived from aquatic microalgae using proprietary precision fermentation and precision photosynthesis platforms. Its product portfolio centers on three families: functional lipids (Omega-3 EPA/DHA oils under the ΩRIGINS™ and DHA ORIGINS® brands), natural colorants (acid-stable blue pigment Galdieria Blue™ / Everzure™), and functional proteins (Kalveā® algal proteins for pet nutrition), designed in France and produced in Europe for nutritional, food & beverage, and pet health manufacturers.

Is Fermentalg a public or private company?

Fermentalg is a public company. It is classified as public and is currently operating.

When was Fermentalg founded?

Fermentalg was founded in 2009. It employs 51 to 100 people.

Where is Fermentalg based?

Fermentalg is headquartered in Libourne, France, in the Europe region.

How does Fermentalg make money?

One revenue line is on record: bioSolutions Ingredients Sales.

Who are Fermentalg's main competitors?

Direct peers on record are dsm-firmenich, AlgaEnergy, Roquette, Kalsec, Sensient Technologies, Cyanotech and GNT Group. Broad incumbents are Novonesis, Cargill and ADM.

Does Fermentalg have an API?

No public API is recorded for Fermentalg.

What industry is Fermentalg in?

Fermentalg's product category is Microalgae-derived Bioingredients. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of AFAJAHAF, Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae). Its NAICS code is 311225 and its SIC code is 2070.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageFERMENTALG : Half-year results 2026: Strict financial discipline and a stronger cash position to enter the next growth cycle from the best possible positionFermentalg reported H1 2026 revenue of €7.4 million, down from €7.6 million in H1 2025, with operating income near stable at -€4.3 million. Gross margin rose to 23% on a product mix shift, and the company expects Q4 revenue of €5 million, an annual run rate of €20 million.FinancialContent Business PageFERMENTALG : Résultats semestriels 2026 : Discipline financière stricte et renforcement de la trésorerie pour aborder dans les meilleures conditions le prochain cycle de croissanceFermentalg reported H1 2026 revenue of €7.4M, down from €7.6M, with a gross margin of 23% and operating loss of €4.4M. The company strengthened its financial position with €10.8M cash and €31.9M equity, aiming for €20M annual revenue by Q4 2026.FinancialContent Business PageFERMENTALG : Informations relatives au nombre total de droits de vote et d'actionsFermentalg disclosed its total voting rights and share count as of 30 September 2026, with 119,968,731 shares and 141,730,017 theoretical voting rights. The company, a producer of sustainable biosolutions, is listed on Euronext Growth Paris and received an Exemplaire ESG rating.FinancialContent Business PageFERMENTALG : Informations relatives au nombre total de droits de vote et d'actionsFermentalg disclosed its total voting rights and share count as of 31 August 2026, with 119,939,198 shares and 141,527,832 exercisable voting rights. The company, a producer of sustainable biosolutions, is listed on Euronext Growth Paris and received an Exemplaire ESG rating from EthiFinance.FinancialContent Business PageFERMENTALG : Informations relatives au nombre total de droits de vote et d'actionsFermentalg, a French biotech company specializing in sustainable biosolutions from microorganisms, published a regulatory filing disclosing its share capital structure as of July 31, 2026, comprising 119,939,198 shares. The filing reports 141,695,831 theoretical voting rights and 141,526,159 exercisable voting rights after excluding self-held shares. The company scheduled its H1 2026 results publication for October 6, 2026.FinancialContent Business PageFERMENTALG : Chiffre d'affaires du 1er semestre 2026 : 7,4 MEUR // Croissance des ventes de DHA sur les segments à forte valeur ajoutée et 1ère commande du colorant bleu naturelFermentalg reported H1 2026 revenue of €7.4 million, nearly flat compared to H1 2025 (€7.6 million), but with a significantly improved revenue structure driven by 20% growth in ΩRIGINS™ lipid sales on higher value-added segments reaching a new semester high of nearly €7 million. The company also secured its first commercial order for Galdieria BlueTM natural blue colorant, with industrial production planned for late 2026 in partnership with Huvepharma, following regulatory approvals from the FDA and EFSA.FinancialContent Business PageFERMENTALG : Revenue for the first half of 2026: EUR7.4 million // Growth in DHA sales in high value-added segments and first order of the natural blue colourFermentalg reported unaudited revenue of €7.4 million for the first half of 2026, comparable to €7.6 million in H1 2025, with a notable 20% growth in ΩRIGINS™ lipid sales in high value-added segments reaching nearly €7 million. The company received its first commercial order for Galdieria Blue™ natural blue dye, with industrial-scale production scheduled to launch in fall 2026 through partner Huvepharma, following regulatory approvals from the U.S. FDA and a favorable opinion from EFSA. Fermentalg confirms its 2026 target of €20 million in annual revenue, citing structural growth in its core lipid business and new opportunities driven by rising fish oil prices reopening the aquaculture market.MarketScreenerZonebourse earnings calendar: week of July 13 to 17, 2026The body is a company profile and ratings widget for Fermentalg, with no earnings calendar content. It describes the company's microalgae research and product offerings, but does not report any earnings or financial data.MarketScreenerZonebourse Earnings Calendar: week of July 13 to 17, 2026The body is a company profile and ratings widget for Fermentalg, with no earnings calendar content. It describes the company's microalgae research and product offerings, but does not report any earnings releases or financial data for the week of July 13-17, 2026.FinancialContent Business PageFERMENTALG : Informations relatives au nombre total de droits de vote et d'actionsFermentalg published its monthly regulatory disclosure on July 7, 2026, reporting that as of June 30, 2026, the company's share capital comprised 119,939,198 shares. The theoretical number of voting rights stood at 141,695,831, while the exercisable number (excluding self-held shares) was 141,533,109, in accordance with Article 223-11 of the AMF General Regulations. The next scheduled publication is the H1 2026 revenue report, due on July 16, 2026 after market close.